Predilife S.A.
ALPRE.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.51M
Close$
Share Statistics
| Market cap | $3.51 Million |
|---|---|
| Enterprise Value | $10.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | 0.26 |
| Outstanding Shares | 4,093,482 |
Return
| Return on Equity | 112.67% |
|---|---|
| Return on Assets | -424.88% |
| Return on Invested Capital | 972.76% |
Valuation & Multiples
| P/E Ratio | -0.88 |
|---|---|
| PEG | 6.17 |
| Price to Sales | - |
| Price to Book Ratio | -0.45 |
| Enterprise Value to Revenue | 6.45 |
| Enterprise Value to EBIT | -1.24 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | -1.08 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
March 3, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Predilife S.A.
21 employees
CEO: Stephane Ragusa Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare sol...